Cathie Wood’s ARK Invest Sells Over 630,000 Shares of DocuSign

One of Cathie Wood's ARK Invest exchange-traded funds sold over 630,000 shares of DocuSign on January 7.

Published January 10, 2022, 10:06am ET · 2 min read

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

© AndreyPopov / iStock via Getty Images

One ARK Invest exchange-traded fund run by ETF star Cathie Wood made a huge sale on Friday. Specifically, this fund sold over 630,000 shares of DocuSign Inc. (NASDAQ: DOCU | DOCU Price Prediction), as the price of the fund was down on the day. Note that the fund is down a fair amount over the past year.
[in-text-ad]
It was the ARK Innovation ETF (NYSEARCA: ARKK) that sold 632,851 shares of DocuSign. At Friday’s closing price, this would have valued the sale at roughly $86.0 million. Even though this is a small fraction of the total holdings, every little bit counts. The fund is down 40% in the past year.
[nativounit]
Check out all of ARK Invest’s trades for Friday as well:

Fund Direction Ticker Name Shares
ARKG Buy BLI BERKELEY LIGHTS 108,000
ARKG Buy VCYT VERACYTE 11,700
ARKG Buy RXRX RECURSION PHARMACEUTICALS 63,400
ARKG Buy QSI QUANTUM-SI 94,738
ARKG Buy NRIX NURIX THERAPEUTICS 178,585
ARKG Buy BNR BURNING ROCK BIOTECH 31,621
ARKG Sell TAK TAKEDA PHARMACEUTICAL 571,269
ARKK Buy ZM ZOOM VIDEO COMMUNICATIONS 18,340
ARKK Buy TWLO TWILIO 61,218
ARKK Buy SQ BLOCK 64,852
ARKK Buy ROKU ROKU 122,516
ARKK Buy RBLX ROBLOX 261,211
ARKK Buy PLTR PALANTIR TECHNOLOGIES 249,211
ARKK Buy PATH UIPATH 37,200
ARKK Buy DNA GINKGO BIOWORKS 741,015
ARKK Buy COIN COINBASE GLOBAL 35,284
ARKK Buy CGEN COMPUGEN 28,281
ARKK Sell DOCU DOCUSIGN 632,581
ARKQ Buy MKFG MARKFORGED 27,685
ARKQ Buy AVAV AEROVIRONMENT 41,049
ARKW Buy RBLX ROBLOX 61,435
ARKW Buy ROKU ROKU 29,397
ARKW Buy VCYT VERACYTE 14,800
ARKW Sell TSLA TESLA 11,496
ARKX Buy MKFG MARKFORGED 26,508

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
[recirclink id=1026436][wallst_email_signup]

Contact [email protected] for any questions or corrections.

Chris Lange

Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.

His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.

When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.

All articles →